ESMO Open Oncology

A randomized, placebo-controlled, phase II study of docetaxel and platinum with or without erlotinib in recurrent/metastatic head and neck squamous-cell carcinomas

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →